Heterologous production of secondary metabolites as pharmaceuticals in Saccharomyces cerevisiae
- 30 May 2008
- journal article
- review article
- Published by Springer Nature in Biotechnology Letters
- Vol. 30 (7) , 1121-1137
Abstract
Heterologous expression of genes involved in the biosynthesis of various products is of increasing interest in biotechnology and in drug research and development. Microbial cells are most appropriate for this purpose. Availability of more microbial genomic sequences in recent years has greatly facilitated the elucidation of metabolic and regulatory networks and helped gain overproduction of desired metabolites or create novel production of commercially important compounds. Saccharomyces cerevisiae, as one of the most intensely studied eukaryotic model organisms with a rich density of knowledge detailing its genetics, biochemistry, physiology, and large-scale fermentation performance, can be capitalized upon to enable a substantial increase in the industrial application of this yeast. In this review, we describe recent efforts made to produce commercial secondary metabolites in Saccharomyces cerevisiae as pharmaceuticals. As natural products are increasingly becoming the center of attention of the pharmaceutical and nutraceutical industries, such as naringenin, coumarate, artemisinin, taxol, amorphadiene and vitamin C, the use of S. cerevisiae for their production is only expected to expand in the future, further allowing the biosynthesis of novel molecular structures with unique properties.Keywords
This publication has 68 references indexed in Scilit:
- Biosynthesis of Vitamin C by Yeast Leads to Increased Stress ResistancePLOS ONE, 2007
- Metabolic engineering of sesquiterpene metabolism in yeastBiotechnology and Bioengineering, 2006
- Production of Resveratrol in Recombinant MicroorganismsApplied and Environmental Microbiology, 2006
- Production of the antimalarial drug precursor artemisinic acid in engineered yeastNature, 2006
- Free radicals, metals and antioxidants in oxidative stress-induced cancerChemico-Biological Interactions, 2006
- Enhancement of Isoflavone Synthase Activity by Co-expression of P450 Reductase from RiceBiotechnology Letters, 2005
- Life with 6000 GenesScience, 1996
- Vitamin C: Newer Insights into Its Biochemical FunctionsNutrition Reviews, 1991
- Plant volatiles as insect attractantsCritical Reviews in Plant Sciences, 1987
- New Concepts in the Biology and Biochemistry of Ascorbic AcidNew England Journal of Medicine, 1986